Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$973.80 5.80 (0.6%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 101.95(B)
Last Volume: 351,356 Avg Vol: 769,142
52 Week Range: $692.45 - $993.35
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 24,729 84,192 120,701 282,978
Total Sell Value $23,631,267 $76,701,012 $107,160,703 $220,505,683
Total People Sold 7 13 15 17
Total Sell Transactions 14 38 55 116
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 1366
  Page 20 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Zoghbi Huda Y Director   –       •      –    2021-09-13 4 AS $651.10 $1,302 D/D (2) 891 -3%     
   Zoghbi Huda Y Director   –       •      –    2021-09-13 4 OE $391.92 $784 D/D 2 893     -
   Brown Michael S Director   –       •      –    2021-09-13 4 AS $636.74 $6,289,792 D/D (9,704) 891 -3%     
   Brown Michael S Director   –       •      –    2021-09-13 4 OE $380.95 $3,930,684 D/D 9,704 10,595     -
   Tessier-Lavigne Marc Director   –       •      –    2021-09-13 4 AS $636.64 $8,181,827 D/D (12,750) 2,078 -3%     
   Tessier-Lavigne Marc Director   –       •      –    2021-09-13 4 OE $273.67 $3,489,293 D/D 12,750 14,828     -
   Goldstein Joseph L Director   –       •      –    2021-09-10 4 AS $650.00 $1,611,350 D/D (2,479) 5,891 -4%     
   Goldstein Joseph L Director   –       •      –    2021-09-10 4 OE $380.95 $944,375 D/D 2,479 8,370     -
   Mccourt Marion EVP Commercial   •       –      –    2021-09-01 4 AS $674.72 $674,720 D/D (1,000) 17,038 -7%     
   Mccourt Marion EVP Commercial   •       –      –    2021-09-01 4 OE $342.93 $342,930 D/D 1,000 18,038     -
   Ryan Arthur F Director   –       •      –    2021-09-01 4 AS $672.75 $67,628 D/D (100) 23,291 -7%     
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-31 4 D $675.03 $619,003 D/D (917) 25,986     -
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-31 4 OE $555.67 $555,670 D/D 1,000 26,903     -
   Sing George L Director   –       •      –    2021-08-30 4 S $670.00 $369,100 I/I (550) 1,750 8%     
   Sing George L Director   –       •      –    2021-08-30 4 S $670.00 $672,500 D/D (1,000) 42,858 8%     
   Poon Christine A Director   –       •      –    2021-08-27 4 S $662.62 $10,021,406 D/D (15,000) 1,681 9%     
   Poon Christine A Director   –       •      –    2021-08-27 4 OE $57.11 $856,650 D/D 15,000 16,681     -
   Sing George L Director   –       •      –    2021-08-26 4 S $672.00 $100,800 I/I (150) 1,000 9%     
   Vagelos P Roy Director   –       •      –    2021-08-25 4 D $667.39 $32,890,314 D/D (49,282) 316,808     -
   Vagelos P Roy Director   –       •      –    2021-08-25 4 OE $179.13 $13,434,750 D/D 75,000 366,090     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2021-08-23 4 AS $661.80 $2,266,817 D/D (3,425) 13,182 -6%     
   Fenimore Christopher R. SVP Controller   •       –      –    2021-08-23 4 AS $655.00 $3,133,037 D/D (4,781) 27,739 -6%     
   Fenimore Christopher R. SVP Controller   •       –      –    2021-08-20 4/A D $664.85 $5,796,827 D/D (8,719) 19,020     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2021-08-20 4 D $664.85 $4,371,389 D/D (6,575) 16,607     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2021-08-20 4 OE $179.13 $1,791,300 D/D 10,000 23,182     -
  1366 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 20 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us